Absorption |
Blood-Brain Barrier | BBB- | 0.7537 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2- | 0.7109 |
P-glycoprotein Substrate | Substrate | 0.8004 |
P-glycoprotein Inhibitor | Inhibitor | 0.5397 |
Inhibitor | 0.8569 |
Renal Organic Cation Transporter | Non-inhibitor | 0.7886 |
Distribution |
Subcellular localization | Mitochondria | 0.5005 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.6303 |
CYP450 2D6 Substrate | Substrate | 0.5139 |
CYP450 3A4 Substrate | Substrate | 0.6828 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8424 |
CYP450 2C9 Inhibitor | Inhibitor | 0.5937 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8889 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8323 |
CYP450 3A4 Inhibitor | Inhibitor | 0.9268 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5935 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8528 |
Inhibitor | 0.7606 |
AMES Toxicity | Non AMES toxic | 0.5790 |
Carcinogens | Non-carcinogens | 0.5106 |
Fish Toxicity | High FHMT | 0.9488 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8972 |
Honey Bee Toxicity | Low HBT | 0.6900 |
Biodegradation | Not ready biodegradable | 0.8647 |
Acute Oral Toxicity | III | 0.5170 |
Carcinogenicity (Three-class) | Non-required | 0.5925 |